Global Intravitreal Injection Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
Intravitreal injection is a drug that is injected directly into the vitreous cavity of the eye and is mainly used to treat various fundus diseases.
The global Intravitreal Injection market size is projected to grow from US$ million in 2023 to US$ million in 2030; it is expected to grow at a CAGR of % from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Intravitreal Injection Industry Forecast” looks at past sales and reviews total world Intravitreal Injection sales in 2023, providing a comprehensive analysis by region and market sector of projected Intravitreal Injection sales for 2024 through 2030. With Intravitreal Injection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Intravitreal Injection industry.
This Insight Report provides a comprehensive analysis of the global Intravitreal Injection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Intravitreal Injection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Intravitreal Injection market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Intravitreal Injection and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Intravitreal Injection.
United States market for Intravitreal Injection is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Intravitreal Injection is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Intravitreal Injection is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Intravitreal Injection players cover Sanofi, Novartis, Bayer, Genentech and Apellis Pharmaceuticals, Inc., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Intravitreal Injection market by product type, application, key manufacturers and key regions and countries.
Segmentation by type
What is the 10-year outlook for the global Intravitreal Injection market?
What factors are driving Intravitreal Injection market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Intravitreal Injection market opportunities vary by end market size?
How does Intravitreal Injection break out type, application?
Intravitreal injection is a drug that is injected directly into the vitreous cavity of the eye and is mainly used to treat various fundus diseases.
The global Intravitreal Injection market size is projected to grow from US$ million in 2023 to US$ million in 2030; it is expected to grow at a CAGR of % from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Intravitreal Injection Industry Forecast” looks at past sales and reviews total world Intravitreal Injection sales in 2023, providing a comprehensive analysis by region and market sector of projected Intravitreal Injection sales for 2024 through 2030. With Intravitreal Injection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Intravitreal Injection industry.
This Insight Report provides a comprehensive analysis of the global Intravitreal Injection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Intravitreal Injection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Intravitreal Injection market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Intravitreal Injection and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Intravitreal Injection.
United States market for Intravitreal Injection is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Intravitreal Injection is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Intravitreal Injection is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Intravitreal Injection players cover Sanofi, Novartis, Bayer, Genentech and Apellis Pharmaceuticals, Inc., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Intravitreal Injection market by product type, application, key manufacturers and key regions and countries.
Segmentation by type
- Ranibizumab
- Bevacizumab
- Aflibercept
- Brolucizumab
- Faricimab
- Others
- Diabetic Eye Disease
- AMD
- Retinal Vein Occlusion
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Sanofi
- Novartis
- Bayer
- Genentech
- Apellis Pharmaceuticals, Inc.
- Coherus BioSciences Inc.
- Iveric Bio
- Regeneron
- Roche
- Qilu Pharmaceutical Co.,Ltd.
- Chengdu Kanghong Pharmaceutical Group
What is the 10-year outlook for the global Intravitreal Injection market?
What factors are driving Intravitreal Injection market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Intravitreal Injection market opportunities vary by end market size?
How does Intravitreal Injection break out type, application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Intravitreal Injection Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Intravitreal Injection by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Intravitreal Injection by Country/Region, 2019, 2023 & 2030
2.2 Intravitreal Injection Segment by Type
2.2.1 Ranibizumab
2.2.2 Bevacizumab
2.2.3 Aflibercept
2.2.4 Brolucizumab
2.2.5 Faricimab
2.2.6 Others
2.3 Intravitreal Injection Sales by Type
2.3.1 Global Intravitreal Injection Sales Market Share by Type (2019-2024)
2.3.2 Global Intravitreal Injection Revenue and Market Share by Type (2019-2024)
2.3.3 Global Intravitreal Injection Sale Price by Type (2019-2024)
2.4 Intravitreal Injection Segment by Application
2.4.1 Diabetic Eye Disease
2.4.2 AMD
2.4.3 Retinal Vein Occlusion
2.4.4 Others
2.5 Intravitreal Injection Sales by Application
2.5.1 Global Intravitreal Injection Sale Market Share by Application (2019-2024)
2.5.2 Global Intravitreal Injection Revenue and Market Share by Application (2019-2024)
2.5.3 Global Intravitreal Injection Sale Price by Application (2019-2024)
3 GLOBAL INTRAVITREAL INJECTION BY COMPANY
3.1 Global Intravitreal Injection Breakdown Data by Company
3.1.1 Global Intravitreal Injection Annual Sales by Company (2019-2024)
3.1.2 Global Intravitreal Injection Sales Market Share by Company (2019-2024)
3.2 Global Intravitreal Injection Annual Revenue by Company (2019-2024)
3.2.1 Global Intravitreal Injection Revenue by Company (2019-2024)
3.2.2 Global Intravitreal Injection Revenue Market Share by Company (2019-2024)
3.3 Global Intravitreal Injection Sale Price by Company
3.4 Key Manufacturers Intravitreal Injection Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Intravitreal Injection Product Location Distribution
3.4.2 Players Intravitreal Injection Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR INTRAVITREAL INJECTION BY GEOGRAPHIC REGION
4.1 World Historic Intravitreal Injection Market Size by Geographic Region (2019-2024)
4.1.1 Global Intravitreal Injection Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Intravitreal Injection Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Intravitreal Injection Market Size by Country/Region (2019-2024)
4.2.1 Global Intravitreal Injection Annual Sales by Country/Region (2019-2024)
4.2.2 Global Intravitreal Injection Annual Revenue by Country/Region (2019-2024)
4.3 Americas Intravitreal Injection Sales Growth
4.4 APAC Intravitreal Injection Sales Growth
4.5 Europe Intravitreal Injection Sales Growth
4.6 Middle East & Africa Intravitreal Injection Sales Growth
5 AMERICAS
5.1 Americas Intravitreal Injection Sales by Country
5.1.1 Americas Intravitreal Injection Sales by Country (2019-2024)
5.1.2 Americas Intravitreal Injection Revenue by Country (2019-2024)
5.2 Americas Intravitreal Injection Sales by Type
5.3 Americas Intravitreal Injection Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Intravitreal Injection Sales by Region
6.1.1 APAC Intravitreal Injection Sales by Region (2019-2024)
6.1.2 APAC Intravitreal Injection Revenue by Region (2019-2024)
6.2 APAC Intravitreal Injection Sales by Type
6.3 APAC Intravitreal Injection Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Intravitreal Injection by Country
7.1.1 Europe Intravitreal Injection Sales by Country (2019-2024)
7.1.2 Europe Intravitreal Injection Revenue by Country (2019-2024)
7.2 Europe Intravitreal Injection Sales by Type
7.3 Europe Intravitreal Injection Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Intravitreal Injection by Country
8.1.1 Middle East & Africa Intravitreal Injection Sales by Country (2019-2024)
8.1.2 Middle East & Africa Intravitreal Injection Revenue by Country (2019-2024)
8.2 Middle East & Africa Intravitreal Injection Sales by Type
8.3 Middle East & Africa Intravitreal Injection Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Intravitreal Injection
10.3 Manufacturing Process Analysis of Intravitreal Injection
10.4 Industry Chain Structure of Intravitreal Injection
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Intravitreal Injection Distributors
11.3 Intravitreal Injection Customer
12 WORLD FORECAST REVIEW FOR INTRAVITREAL INJECTION BY GEOGRAPHIC REGION
12.1 Global Intravitreal Injection Market Size Forecast by Region
12.1.1 Global Intravitreal Injection Forecast by Region (2025-2030)
12.1.2 Global Intravitreal Injection Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Intravitreal Injection Forecast by Type
12.7 Global Intravitreal Injection Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Sanofi
13.1.1 Sanofi Company Information
13.1.2 Sanofi Intravitreal Injection Product Portfolios and Specifications
13.1.3 Sanofi Intravitreal Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Sanofi Main Business Overview
13.1.5 Sanofi Latest Developments
13.2 Novartis
13.2.1 Novartis Company Information
13.2.2 Novartis Intravitreal Injection Product Portfolios and Specifications
13.2.3 Novartis Intravitreal Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Novartis Main Business Overview
13.2.5 Novartis Latest Developments
13.3 Bayer
13.3.1 Bayer Company Information
13.3.2 Bayer Intravitreal Injection Product Portfolios and Specifications
13.3.3 Bayer Intravitreal Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Bayer Main Business Overview
13.3.5 Bayer Latest Developments
13.4 Genentech
13.4.1 Genentech Company Information
13.4.2 Genentech Intravitreal Injection Product Portfolios and Specifications
13.4.3 Genentech Intravitreal Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Genentech Main Business Overview
13.4.5 Genentech Latest Developments
13.5 Apellis Pharmaceuticals, Inc.
13.5.1 Apellis Pharmaceuticals, Inc. Company Information
13.5.2 Apellis Pharmaceuticals, Inc. Intravitreal Injection Product Portfolios and Specifications
13.5.3 Apellis Pharmaceuticals, Inc. Intravitreal Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Apellis Pharmaceuticals, Inc. Main Business Overview
13.5.5 Apellis Pharmaceuticals, Inc. Latest Developments
13.6 Coherus BioSciences Inc.
13.6.1 Coherus BioSciences Inc. Company Information
13.6.2 Coherus BioSciences Inc. Intravitreal Injection Product Portfolios and Specifications
13.6.3 Coherus BioSciences Inc. Intravitreal Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Coherus BioSciences Inc. Main Business Overview
13.6.5 Coherus BioSciences Inc. Latest Developments
13.7 Iveric Bio
13.7.1 Iveric Bio
Company Information
13.7.2 Iveric Bio
Intravitreal Injection Product Portfolios and Specifications
13.7.3 Iveric Bio
Intravitreal Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Iveric Bio
Main Business Overview
13.7.5 Iveric Bio
Latest Developments
13.8 Regeneron
13.8.1 Regeneron Company Information
13.8.2 Regeneron Intravitreal Injection Product Portfolios and Specifications
13.8.3 Regeneron Intravitreal Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Regeneron Main Business Overview
13.8.5 Regeneron Latest Developments
13.9 Roche
13.9.1 Roche Company Information
13.9.2 Roche Intravitreal Injection Product Portfolios and Specifications
13.9.3 Roche Intravitreal Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Roche Main Business Overview
13.9.5 Roche Latest Developments
13.10 Qilu Pharmaceutical Co.,Ltd.
13.10.1 Qilu Pharmaceutical Co.,Ltd. Company Information
13.10.2 Qilu Pharmaceutical Co.,Ltd. Intravitreal Injection Product Portfolios and Specifications
13.10.3 Qilu Pharmaceutical Co.,Ltd. Intravitreal Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Qilu Pharmaceutical Co.,Ltd. Main Business Overview
13.10.5 Qilu Pharmaceutical Co.,Ltd. Latest Developments
13.11 Chengdu Kanghong Pharmaceutical Group
13.11.1 Chengdu Kanghong Pharmaceutical Group Company Information
13.11.2 Chengdu Kanghong Pharmaceutical Group Intravitreal Injection Product Portfolios and Specifications
13.11.3 Chengdu Kanghong Pharmaceutical Group Intravitreal Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Chengdu Kanghong Pharmaceutical Group Main Business Overview
13.11.5 Chengdu Kanghong Pharmaceutical Group Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Intravitreal Injection Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Intravitreal Injection by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Intravitreal Injection by Country/Region, 2019, 2023 & 2030
2.2 Intravitreal Injection Segment by Type
2.2.1 Ranibizumab
2.2.2 Bevacizumab
2.2.3 Aflibercept
2.2.4 Brolucizumab
2.2.5 Faricimab
2.2.6 Others
2.3 Intravitreal Injection Sales by Type
2.3.1 Global Intravitreal Injection Sales Market Share by Type (2019-2024)
2.3.2 Global Intravitreal Injection Revenue and Market Share by Type (2019-2024)
2.3.3 Global Intravitreal Injection Sale Price by Type (2019-2024)
2.4 Intravitreal Injection Segment by Application
2.4.1 Diabetic Eye Disease
2.4.2 AMD
2.4.3 Retinal Vein Occlusion
2.4.4 Others
2.5 Intravitreal Injection Sales by Application
2.5.1 Global Intravitreal Injection Sale Market Share by Application (2019-2024)
2.5.2 Global Intravitreal Injection Revenue and Market Share by Application (2019-2024)
2.5.3 Global Intravitreal Injection Sale Price by Application (2019-2024)
3 GLOBAL INTRAVITREAL INJECTION BY COMPANY
3.1 Global Intravitreal Injection Breakdown Data by Company
3.1.1 Global Intravitreal Injection Annual Sales by Company (2019-2024)
3.1.2 Global Intravitreal Injection Sales Market Share by Company (2019-2024)
3.2 Global Intravitreal Injection Annual Revenue by Company (2019-2024)
3.2.1 Global Intravitreal Injection Revenue by Company (2019-2024)
3.2.2 Global Intravitreal Injection Revenue Market Share by Company (2019-2024)
3.3 Global Intravitreal Injection Sale Price by Company
3.4 Key Manufacturers Intravitreal Injection Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Intravitreal Injection Product Location Distribution
3.4.2 Players Intravitreal Injection Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR INTRAVITREAL INJECTION BY GEOGRAPHIC REGION
4.1 World Historic Intravitreal Injection Market Size by Geographic Region (2019-2024)
4.1.1 Global Intravitreal Injection Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Intravitreal Injection Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Intravitreal Injection Market Size by Country/Region (2019-2024)
4.2.1 Global Intravitreal Injection Annual Sales by Country/Region (2019-2024)
4.2.2 Global Intravitreal Injection Annual Revenue by Country/Region (2019-2024)
4.3 Americas Intravitreal Injection Sales Growth
4.4 APAC Intravitreal Injection Sales Growth
4.5 Europe Intravitreal Injection Sales Growth
4.6 Middle East & Africa Intravitreal Injection Sales Growth
5 AMERICAS
5.1 Americas Intravitreal Injection Sales by Country
5.1.1 Americas Intravitreal Injection Sales by Country (2019-2024)
5.1.2 Americas Intravitreal Injection Revenue by Country (2019-2024)
5.2 Americas Intravitreal Injection Sales by Type
5.3 Americas Intravitreal Injection Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Intravitreal Injection Sales by Region
6.1.1 APAC Intravitreal Injection Sales by Region (2019-2024)
6.1.2 APAC Intravitreal Injection Revenue by Region (2019-2024)
6.2 APAC Intravitreal Injection Sales by Type
6.3 APAC Intravitreal Injection Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Intravitreal Injection by Country
7.1.1 Europe Intravitreal Injection Sales by Country (2019-2024)
7.1.2 Europe Intravitreal Injection Revenue by Country (2019-2024)
7.2 Europe Intravitreal Injection Sales by Type
7.3 Europe Intravitreal Injection Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Intravitreal Injection by Country
8.1.1 Middle East & Africa Intravitreal Injection Sales by Country (2019-2024)
8.1.2 Middle East & Africa Intravitreal Injection Revenue by Country (2019-2024)
8.2 Middle East & Africa Intravitreal Injection Sales by Type
8.3 Middle East & Africa Intravitreal Injection Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Intravitreal Injection
10.3 Manufacturing Process Analysis of Intravitreal Injection
10.4 Industry Chain Structure of Intravitreal Injection
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Intravitreal Injection Distributors
11.3 Intravitreal Injection Customer
12 WORLD FORECAST REVIEW FOR INTRAVITREAL INJECTION BY GEOGRAPHIC REGION
12.1 Global Intravitreal Injection Market Size Forecast by Region
12.1.1 Global Intravitreal Injection Forecast by Region (2025-2030)
12.1.2 Global Intravitreal Injection Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Intravitreal Injection Forecast by Type
12.7 Global Intravitreal Injection Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Sanofi
13.1.1 Sanofi Company Information
13.1.2 Sanofi Intravitreal Injection Product Portfolios and Specifications
13.1.3 Sanofi Intravitreal Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Sanofi Main Business Overview
13.1.5 Sanofi Latest Developments
13.2 Novartis
13.2.1 Novartis Company Information
13.2.2 Novartis Intravitreal Injection Product Portfolios and Specifications
13.2.3 Novartis Intravitreal Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Novartis Main Business Overview
13.2.5 Novartis Latest Developments
13.3 Bayer
13.3.1 Bayer Company Information
13.3.2 Bayer Intravitreal Injection Product Portfolios and Specifications
13.3.3 Bayer Intravitreal Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Bayer Main Business Overview
13.3.5 Bayer Latest Developments
13.4 Genentech
13.4.1 Genentech Company Information
13.4.2 Genentech Intravitreal Injection Product Portfolios and Specifications
13.4.3 Genentech Intravitreal Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Genentech Main Business Overview
13.4.5 Genentech Latest Developments
13.5 Apellis Pharmaceuticals, Inc.
13.5.1 Apellis Pharmaceuticals, Inc. Company Information
13.5.2 Apellis Pharmaceuticals, Inc. Intravitreal Injection Product Portfolios and Specifications
13.5.3 Apellis Pharmaceuticals, Inc. Intravitreal Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Apellis Pharmaceuticals, Inc. Main Business Overview
13.5.5 Apellis Pharmaceuticals, Inc. Latest Developments
13.6 Coherus BioSciences Inc.
13.6.1 Coherus BioSciences Inc. Company Information
13.6.2 Coherus BioSciences Inc. Intravitreal Injection Product Portfolios and Specifications
13.6.3 Coherus BioSciences Inc. Intravitreal Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Coherus BioSciences Inc. Main Business Overview
13.6.5 Coherus BioSciences Inc. Latest Developments
13.7 Iveric Bio
13.7.1 Iveric Bio
Company Information
13.7.2 Iveric Bio
Intravitreal Injection Product Portfolios and Specifications
13.7.3 Iveric Bio
Intravitreal Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Iveric Bio
Main Business Overview
13.7.5 Iveric Bio
Latest Developments
13.8 Regeneron
13.8.1 Regeneron Company Information
13.8.2 Regeneron Intravitreal Injection Product Portfolios and Specifications
13.8.3 Regeneron Intravitreal Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Regeneron Main Business Overview
13.8.5 Regeneron Latest Developments
13.9 Roche
13.9.1 Roche Company Information
13.9.2 Roche Intravitreal Injection Product Portfolios and Specifications
13.9.3 Roche Intravitreal Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Roche Main Business Overview
13.9.5 Roche Latest Developments
13.10 Qilu Pharmaceutical Co.,Ltd.
13.10.1 Qilu Pharmaceutical Co.,Ltd. Company Information
13.10.2 Qilu Pharmaceutical Co.,Ltd. Intravitreal Injection Product Portfolios and Specifications
13.10.3 Qilu Pharmaceutical Co.,Ltd. Intravitreal Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Qilu Pharmaceutical Co.,Ltd. Main Business Overview
13.10.5 Qilu Pharmaceutical Co.,Ltd. Latest Developments
13.11 Chengdu Kanghong Pharmaceutical Group
13.11.1 Chengdu Kanghong Pharmaceutical Group Company Information
13.11.2 Chengdu Kanghong Pharmaceutical Group Intravitreal Injection Product Portfolios and Specifications
13.11.3 Chengdu Kanghong Pharmaceutical Group Intravitreal Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Chengdu Kanghong Pharmaceutical Group Main Business Overview
13.11.5 Chengdu Kanghong Pharmaceutical Group Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Intravitreal Injection Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Intravitreal Injection Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Ranibizumab
Table 4. Major Players of Bevacizumab
Table 5. Major Players of Aflibercept
Table 6. Major Players of Brolucizumab
Table 7. Major Players of Faricimab
Table 8. Major Players of Others
Table 9. Global Intravitreal Injection Sales by Type (2019-2024) & (K Units)
Table 10. Global Intravitreal Injection Sales Market Share by Type (2019-2024)
Table 11. Global Intravitreal Injection Revenue by Type (2019-2024) & ($ million)
Table 12. Global Intravitreal Injection Revenue Market Share by Type (2019-2024)
Table 13. Global Intravitreal Injection Sale Price by Type (2019-2024) & (US$/Unit)
Table 14. Global Intravitreal Injection Sales by Application (2019-2024) & (K Units)
Table 15. Global Intravitreal Injection Sales Market Share by Application (2019-2024)
Table 16. Global Intravitreal Injection Revenue by Application (2019-2024)
Table 17. Global Intravitreal Injection Revenue Market Share by Application (2019-2024)
Table 18. Global Intravitreal Injection Sale Price by Application (2019-2024) & (US$/Unit)
Table 19. Global Intravitreal Injection Sales by Company (2019-2024) & (K Units)
Table 20. Global Intravitreal Injection Sales Market Share by Company (2019-2024)
Table 21. Global Intravitreal Injection Revenue by Company (2019-2024) ($ Millions)
Table 22. Global Intravitreal Injection Revenue Market Share by Company (2019-2024)
Table 23. Global Intravitreal Injection Sale Price by Company (2019-2024) & (US$/Unit)
Table 24. Key Manufacturers Intravitreal Injection Producing Area Distribution and Sales Area
Table 25. Players Intravitreal Injection Products Offered
Table 26. Intravitreal Injection Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 27. New Products and Potential Entrants
Table 28. Mergers & Acquisitions, Expansion
Table 29. Global Intravitreal Injection Sales by Geographic Region (2019-2024) & (K Units)
Table 30. Global Intravitreal Injection Sales Market Share Geographic Region (2019-2024)
Table 31. Global Intravitreal Injection Revenue by Geographic Region (2019-2024) & ($ millions)
Table 32. Global Intravitreal Injection Revenue Market Share by Geographic Region (2019-2024)
Table 33. Global Intravitreal Injection Sales by Country/Region (2019-2024) & (K Units)
Table 34. Global Intravitreal Injection Sales Market Share by Country/Region (2019-2024)
Table 35. Global Intravitreal Injection Revenue by Country/Region (2019-2024) & ($ millions)
Table 36. Global Intravitreal Injection Revenue Market Share by Country/Region (2019-2024)
Table 37. Americas Intravitreal Injection Sales by Country (2019-2024) & (K Units)
Table 38. Americas Intravitreal Injection Sales Market Share by Country (2019-2024)
Table 39. Americas Intravitreal Injection Revenue by Country (2019-2024) & ($ Millions)
Table 40. Americas Intravitreal Injection Revenue Market Share by Country (2019-2024)
Table 41. Americas Intravitreal Injection Sales by Type (2019-2024) & (K Units)
Table 42. Americas Intravitreal Injection Sales by Application (2019-2024) & (K Units)
Table 43. APAC Intravitreal Injection Sales by Region (2019-2024) & (K Units)
Table 44. APAC Intravitreal Injection Sales Market Share by Region (2019-2024)
Table 45. APAC Intravitreal Injection Revenue by Region (2019-2024) & ($ Millions)
Table 46. APAC Intravitreal Injection Revenue Market Share by Region (2019-2024)
Table 47. APAC Intravitreal Injection Sales by Type (2019-2024) & (K Units)
Table 48. APAC Intravitreal Injection Sales by Application (2019-2024) & (K Units)
Table 49. Europe Intravitreal Injection Sales by Country (2019-2024) & (K Units)
Table 50. Europe Intravitreal Injection Sales Market Share by Country (2019-2024)
Table 51. Europe Intravitreal Injection Revenue by Country (2019-2024) & ($ Millions)
Table 52. Europe Intravitreal Injection Revenue Market Share by Country (2019-2024)
Table 53. Europe Intravitreal Injection Sales by Type (2019-2024) & (K Units)
Table 54. Europe Intravitreal Injection Sales by Application (2019-2024) & (K Units)
Table 55. Middle East & Africa Intravitreal Injection Sales by Country (2019-2024) & (K Units)
Table 56. Middle East & Africa Intravitreal Injection Sales Market Share by Country (2019-2024)
Table 57. Middle East & Africa Intravitreal Injection Revenue by Country (2019-2024) & ($ Millions)
Table 58. Middle East & Africa Intravitreal Injection Revenue Market Share by Country (2019-2024)
Table 59. Middle East & Africa Intravitreal Injection Sales by Type (2019-2024) & (K Units)
Table 60. Middle East & Africa Intravitreal Injection Sales by Application (2019-2024) & (K Units)
Table 61. Key Market Drivers & Growth Opportunities of Intravitreal Injection
Table 62. Key Market Challenges & Risks of Intravitreal Injection
Table 63. Key Industry Trends of Intravitreal Injection
Table 64. Intravitreal Injection Raw Material
Table 65. Key Suppliers of Raw Materials
Table 66. Intravitreal Injection Distributors List
Table 67. Intravitreal Injection Customer List
Table 68. Global Intravitreal Injection Sales Forecast by Region (2025-2030) & (K Units)
Table 69. Global Intravitreal Injection Revenue Forecast by Region (2025-2030) & ($ millions)
Table 70. Americas Intravitreal Injection Sales Forecast by Country (2025-2030) & (K Units)
Table 71. Americas Intravitreal Injection Revenue Forecast by Country (2025-2030) & ($ millions)
Table 72. APAC Intravitreal Injection Sales Forecast by Region (2025-2030) & (K Units)
Table 73. APAC Intravitreal Injection Revenue Forecast by Region (2025-2030) & ($ millions)
Table 74. Europe Intravitreal Injection Sales Forecast by Country (2025-2030) & (K Units)
Table 75. Europe Intravitreal Injection Revenue Forecast by Country (2025-2030) & ($ millions)
Table 76. Middle East & Africa Intravitreal Injection Sales Forecast by Country (2025-2030) & (K Units)
Table 77. Middle East & Africa Intravitreal Injection Revenue Forecast by Country (2025-2030) & ($ millions)
Table 78. Global Intravitreal Injection Sales Forecast by Type (2025-2030) & (K Units)
Table 79. Global Intravitreal Injection Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 80. Global Intravitreal Injection Sales Forecast by Application (2025-2030) & (K Units)
Table 81. Global Intravitreal Injection Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 82. Sanofi Basic Information, Intravitreal Injection Manufacturing Base, Sales Area and Its Competitors
Table 83. Sanofi Intravitreal Injection Product Portfolios and Specifications
Table 84. Sanofi Intravitreal Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 85. Sanofi Main Business
Table 86. Sanofi Latest Developments
Table 87. Novartis Basic Information, Intravitreal Injection Manufacturing Base, Sales Area and Its Competitors
Table 88. Novartis Intravitreal Injection Product Portfolios and Specifications
Table 89. Novartis Intravitreal Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 90. Novartis Main Business
Table 91. Novartis Latest Developments
Table 92. Bayer Basic Information, Intravitreal Injection Manufacturing Base, Sales Area and Its Competitors
Table 93. Bayer Intravitreal Injection Product Portfolios and Specifications
Table 94. Bayer Intravitreal Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 95. Bayer Main Business
Table 96. Bayer Latest Developments
Table 97. Genentech Basic Information, Intravitreal Injection Manufacturing Base, Sales Area and Its Competitors
Table 98. Genentech Intravitreal Injection Product Portfolios and Specifications
Table 99. Genentech Intravitreal Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 100. Genentech Main Business
Table 101. Genentech Latest Developments
Table 102. Apellis Pharmaceuticals, Inc. Basic Information, Intravitreal Injection Manufacturing Base, Sales Area and Its Competitors
Table 103. Apellis Pharmaceuticals, Inc. Intravitreal Injection Product Portfolios and Specifications
Table 104. Apellis Pharmaceuticals, Inc. Intravitreal Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 105. Apellis Pharmaceuticals, Inc. Main Business
Table 106. Apellis Pharmaceuticals, Inc. Latest Developments
Table 107. Coherus BioSciences Inc. Basic Information, Intravitreal Injection Manufacturing Base, Sales Area and Its Competitors
Table 108. Coherus BioSciences Inc. Intravitreal Injection Product Portfolios and Specifications
Table 109. Coherus BioSciences Inc. Intravitreal Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 110. Coherus BioSciences Inc. Main Business
Table 111. Coherus BioSciences Inc. Latest Developments
Table 112. Iveric Bio
Basic Information, Intravitreal Injection Manufacturing Base, Sales Area and Its Competitors
Table 113. Iveric Bio
Intravitreal Injection Product Portfolios and Specifications
Table 114. Iveric Bio
Intravitreal Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 115. Iveric Bio
Main Business
Table 116. Iveric Bio
Latest Developments
Table 117. Regeneron Basic Information, Intravitreal Injection Manufacturing Base, Sales Area and Its Competitors
Table 118. Regeneron Intravitreal Injection Product Portfolios and Specifications
Table 119. Regeneron Intravitreal Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 120. Regeneron Main Business
Table 121. Regeneron Latest Developments
Table 122. Roche Basic Information, Intravitreal Injection Manufacturing Base, Sales Area and Its Competitors
Table 123. Roche Intravitreal Injection Product Portfolios and Specifications
Table 124. Roche Intravitreal Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 125. Roche Main Business
Table 126. Roche Latest Developments
Table 127. Qilu Pharmaceutical Co.,Ltd. Basic Information, Intravitreal Injection Manufacturing Base, Sales Area and Its Competitors
Table 128. Qilu Pharmaceutical Co.,Ltd. Intravitreal Injection Product Portfolios and Specifications
Table 129. Qilu Pharmaceutical Co.,Ltd. Intravitreal Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 130. Qilu Pharmaceutical Co.,Ltd. Main Business
Table 131. Qilu Pharmaceutical Co.,Ltd. Latest Developments
Table 132. Chengdu Kanghong Pharmaceutical Group Basic Information, Intravitreal Injection Manufacturing Base, Sales Area and Its Competitors
Table 133. Chengdu Kanghong Pharmaceutical Group Intravitreal Injection Product Portfolios and Specifications
Table 134. Chengdu Kanghong Pharmaceutical Group Intravitreal Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 135. Chengdu Kanghong Pharmaceutical Group Main Business
Table 136. Chengdu Kanghong Pharmaceutical Group Latest Developments
Table 1. Intravitreal Injection Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Intravitreal Injection Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Ranibizumab
Table 4. Major Players of Bevacizumab
Table 5. Major Players of Aflibercept
Table 6. Major Players of Brolucizumab
Table 7. Major Players of Faricimab
Table 8. Major Players of Others
Table 9. Global Intravitreal Injection Sales by Type (2019-2024) & (K Units)
Table 10. Global Intravitreal Injection Sales Market Share by Type (2019-2024)
Table 11. Global Intravitreal Injection Revenue by Type (2019-2024) & ($ million)
Table 12. Global Intravitreal Injection Revenue Market Share by Type (2019-2024)
Table 13. Global Intravitreal Injection Sale Price by Type (2019-2024) & (US$/Unit)
Table 14. Global Intravitreal Injection Sales by Application (2019-2024) & (K Units)
Table 15. Global Intravitreal Injection Sales Market Share by Application (2019-2024)
Table 16. Global Intravitreal Injection Revenue by Application (2019-2024)
Table 17. Global Intravitreal Injection Revenue Market Share by Application (2019-2024)
Table 18. Global Intravitreal Injection Sale Price by Application (2019-2024) & (US$/Unit)
Table 19. Global Intravitreal Injection Sales by Company (2019-2024) & (K Units)
Table 20. Global Intravitreal Injection Sales Market Share by Company (2019-2024)
Table 21. Global Intravitreal Injection Revenue by Company (2019-2024) ($ Millions)
Table 22. Global Intravitreal Injection Revenue Market Share by Company (2019-2024)
Table 23. Global Intravitreal Injection Sale Price by Company (2019-2024) & (US$/Unit)
Table 24. Key Manufacturers Intravitreal Injection Producing Area Distribution and Sales Area
Table 25. Players Intravitreal Injection Products Offered
Table 26. Intravitreal Injection Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 27. New Products and Potential Entrants
Table 28. Mergers & Acquisitions, Expansion
Table 29. Global Intravitreal Injection Sales by Geographic Region (2019-2024) & (K Units)
Table 30. Global Intravitreal Injection Sales Market Share Geographic Region (2019-2024)
Table 31. Global Intravitreal Injection Revenue by Geographic Region (2019-2024) & ($ millions)
Table 32. Global Intravitreal Injection Revenue Market Share by Geographic Region (2019-2024)
Table 33. Global Intravitreal Injection Sales by Country/Region (2019-2024) & (K Units)
Table 34. Global Intravitreal Injection Sales Market Share by Country/Region (2019-2024)
Table 35. Global Intravitreal Injection Revenue by Country/Region (2019-2024) & ($ millions)
Table 36. Global Intravitreal Injection Revenue Market Share by Country/Region (2019-2024)
Table 37. Americas Intravitreal Injection Sales by Country (2019-2024) & (K Units)
Table 38. Americas Intravitreal Injection Sales Market Share by Country (2019-2024)
Table 39. Americas Intravitreal Injection Revenue by Country (2019-2024) & ($ Millions)
Table 40. Americas Intravitreal Injection Revenue Market Share by Country (2019-2024)
Table 41. Americas Intravitreal Injection Sales by Type (2019-2024) & (K Units)
Table 42. Americas Intravitreal Injection Sales by Application (2019-2024) & (K Units)
Table 43. APAC Intravitreal Injection Sales by Region (2019-2024) & (K Units)
Table 44. APAC Intravitreal Injection Sales Market Share by Region (2019-2024)
Table 45. APAC Intravitreal Injection Revenue by Region (2019-2024) & ($ Millions)
Table 46. APAC Intravitreal Injection Revenue Market Share by Region (2019-2024)
Table 47. APAC Intravitreal Injection Sales by Type (2019-2024) & (K Units)
Table 48. APAC Intravitreal Injection Sales by Application (2019-2024) & (K Units)
Table 49. Europe Intravitreal Injection Sales by Country (2019-2024) & (K Units)
Table 50. Europe Intravitreal Injection Sales Market Share by Country (2019-2024)
Table 51. Europe Intravitreal Injection Revenue by Country (2019-2024) & ($ Millions)
Table 52. Europe Intravitreal Injection Revenue Market Share by Country (2019-2024)
Table 53. Europe Intravitreal Injection Sales by Type (2019-2024) & (K Units)
Table 54. Europe Intravitreal Injection Sales by Application (2019-2024) & (K Units)
Table 55. Middle East & Africa Intravitreal Injection Sales by Country (2019-2024) & (K Units)
Table 56. Middle East & Africa Intravitreal Injection Sales Market Share by Country (2019-2024)
Table 57. Middle East & Africa Intravitreal Injection Revenue by Country (2019-2024) & ($ Millions)
Table 58. Middle East & Africa Intravitreal Injection Revenue Market Share by Country (2019-2024)
Table 59. Middle East & Africa Intravitreal Injection Sales by Type (2019-2024) & (K Units)
Table 60. Middle East & Africa Intravitreal Injection Sales by Application (2019-2024) & (K Units)
Table 61. Key Market Drivers & Growth Opportunities of Intravitreal Injection
Table 62. Key Market Challenges & Risks of Intravitreal Injection
Table 63. Key Industry Trends of Intravitreal Injection
Table 64. Intravitreal Injection Raw Material
Table 65. Key Suppliers of Raw Materials
Table 66. Intravitreal Injection Distributors List
Table 67. Intravitreal Injection Customer List
Table 68. Global Intravitreal Injection Sales Forecast by Region (2025-2030) & (K Units)
Table 69. Global Intravitreal Injection Revenue Forecast by Region (2025-2030) & ($ millions)
Table 70. Americas Intravitreal Injection Sales Forecast by Country (2025-2030) & (K Units)
Table 71. Americas Intravitreal Injection Revenue Forecast by Country (2025-2030) & ($ millions)
Table 72. APAC Intravitreal Injection Sales Forecast by Region (2025-2030) & (K Units)
Table 73. APAC Intravitreal Injection Revenue Forecast by Region (2025-2030) & ($ millions)
Table 74. Europe Intravitreal Injection Sales Forecast by Country (2025-2030) & (K Units)
Table 75. Europe Intravitreal Injection Revenue Forecast by Country (2025-2030) & ($ millions)
Table 76. Middle East & Africa Intravitreal Injection Sales Forecast by Country (2025-2030) & (K Units)
Table 77. Middle East & Africa Intravitreal Injection Revenue Forecast by Country (2025-2030) & ($ millions)
Table 78. Global Intravitreal Injection Sales Forecast by Type (2025-2030) & (K Units)
Table 79. Global Intravitreal Injection Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 80. Global Intravitreal Injection Sales Forecast by Application (2025-2030) & (K Units)
Table 81. Global Intravitreal Injection Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 82. Sanofi Basic Information, Intravitreal Injection Manufacturing Base, Sales Area and Its Competitors
Table 83. Sanofi Intravitreal Injection Product Portfolios and Specifications
Table 84. Sanofi Intravitreal Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 85. Sanofi Main Business
Table 86. Sanofi Latest Developments
Table 87. Novartis Basic Information, Intravitreal Injection Manufacturing Base, Sales Area and Its Competitors
Table 88. Novartis Intravitreal Injection Product Portfolios and Specifications
Table 89. Novartis Intravitreal Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 90. Novartis Main Business
Table 91. Novartis Latest Developments
Table 92. Bayer Basic Information, Intravitreal Injection Manufacturing Base, Sales Area and Its Competitors
Table 93. Bayer Intravitreal Injection Product Portfolios and Specifications
Table 94. Bayer Intravitreal Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 95. Bayer Main Business
Table 96. Bayer Latest Developments
Table 97. Genentech Basic Information, Intravitreal Injection Manufacturing Base, Sales Area and Its Competitors
Table 98. Genentech Intravitreal Injection Product Portfolios and Specifications
Table 99. Genentech Intravitreal Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 100. Genentech Main Business
Table 101. Genentech Latest Developments
Table 102. Apellis Pharmaceuticals, Inc. Basic Information, Intravitreal Injection Manufacturing Base, Sales Area and Its Competitors
Table 103. Apellis Pharmaceuticals, Inc. Intravitreal Injection Product Portfolios and Specifications
Table 104. Apellis Pharmaceuticals, Inc. Intravitreal Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 105. Apellis Pharmaceuticals, Inc. Main Business
Table 106. Apellis Pharmaceuticals, Inc. Latest Developments
Table 107. Coherus BioSciences Inc. Basic Information, Intravitreal Injection Manufacturing Base, Sales Area and Its Competitors
Table 108. Coherus BioSciences Inc. Intravitreal Injection Product Portfolios and Specifications
Table 109. Coherus BioSciences Inc. Intravitreal Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 110. Coherus BioSciences Inc. Main Business
Table 111. Coherus BioSciences Inc. Latest Developments
Table 112. Iveric Bio
Basic Information, Intravitreal Injection Manufacturing Base, Sales Area and Its Competitors
Table 113. Iveric Bio
Intravitreal Injection Product Portfolios and Specifications
Table 114. Iveric Bio
Intravitreal Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 115. Iveric Bio
Main Business
Table 116. Iveric Bio
Latest Developments
Table 117. Regeneron Basic Information, Intravitreal Injection Manufacturing Base, Sales Area and Its Competitors
Table 118. Regeneron Intravitreal Injection Product Portfolios and Specifications
Table 119. Regeneron Intravitreal Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 120. Regeneron Main Business
Table 121. Regeneron Latest Developments
Table 122. Roche Basic Information, Intravitreal Injection Manufacturing Base, Sales Area and Its Competitors
Table 123. Roche Intravitreal Injection Product Portfolios and Specifications
Table 124. Roche Intravitreal Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 125. Roche Main Business
Table 126. Roche Latest Developments
Table 127. Qilu Pharmaceutical Co.,Ltd. Basic Information, Intravitreal Injection Manufacturing Base, Sales Area and Its Competitors
Table 128. Qilu Pharmaceutical Co.,Ltd. Intravitreal Injection Product Portfolios and Specifications
Table 129. Qilu Pharmaceutical Co.,Ltd. Intravitreal Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 130. Qilu Pharmaceutical Co.,Ltd. Main Business
Table 131. Qilu Pharmaceutical Co.,Ltd. Latest Developments
Table 132. Chengdu Kanghong Pharmaceutical Group Basic Information, Intravitreal Injection Manufacturing Base, Sales Area and Its Competitors
Table 133. Chengdu Kanghong Pharmaceutical Group Intravitreal Injection Product Portfolios and Specifications
Table 134. Chengdu Kanghong Pharmaceutical Group Intravitreal Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 135. Chengdu Kanghong Pharmaceutical Group Main Business
Table 136. Chengdu Kanghong Pharmaceutical Group Latest Developments
LIST OF FIGURES
Figure 1. Picture of Intravitreal Injection
Figure 2. Intravitreal Injection Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Intravitreal Injection Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Intravitreal Injection Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Intravitreal Injection Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Ranibizumab
Figure 10. Product Picture of Bevacizumab
Figure 11. Product Picture of Aflibercept
Figure 12. Product Picture of Brolucizumab
Figure 13. Product Picture of Faricimab
Figure 14. Product Picture of Others
Figure 15. Global Intravitreal Injection Sales Market Share by Type in 2023
Figure 16. Global Intravitreal Injection Revenue Market Share by Type (2019-2024)
Figure 17. Intravitreal Injection Consumed in Diabetic Eye Disease
Figure 18. Global Intravitreal Injection Market: Diabetic Eye Disease (2019-2024) & (K Units)
Figure 19. Intravitreal Injection Consumed in AMD
Figure 20. Global Intravitreal Injection Market: AMD (2019-2024) & (K Units)
Figure 21. Intravitreal Injection Consumed in Retinal Vein Occlusion
Figure 22. Global Intravitreal Injection Market: Retinal Vein Occlusion (2019-2024) & (K Units)
Figure 23. Intravitreal Injection Consumed in Others
Figure 24. Global Intravitreal Injection Market: Others (2019-2024) & (K Units)
Figure 25. Global Intravitreal Injection Sales Market Share by Application (2023)
Figure 26. Global Intravitreal Injection Revenue Market Share by Application in 2023
Figure 27. Intravitreal Injection Sales Market by Company in 2023 (K Units)
Figure 28. Global Intravitreal Injection Sales Market Share by Company in 2023
Figure 29. Intravitreal Injection Revenue Market by Company in 2023 ($ Million)
Figure 30. Global Intravitreal Injection Revenue Market Share by Company in 2023
Figure 31. Global Intravitreal Injection Sales Market Share by Geographic Region (2019-2024)
Figure 32. Global Intravitreal Injection Revenue Market Share by Geographic Region in 2023
Figure 33. Americas Intravitreal Injection Sales 2019-2024 (K Units)
Figure 34. Americas Intravitreal Injection Revenue 2019-2024 ($ Millions)
Figure 35. APAC Intravitreal Injection Sales 2019-2024 (K Units)
Figure 36. APAC Intravitreal Injection Revenue 2019-2024 ($ Millions)
Figure 37. Europe Intravitreal Injection Sales 2019-2024 (K Units)
Figure 38. Europe Intravitreal Injection Revenue 2019-2024 ($ Millions)
Figure 39. Middle East & Africa Intravitreal Injection Sales 2019-2024 (K Units)
Figure 40. Middle East & Africa Intravitreal Injection Revenue 2019-2024 ($ Millions)
Figure 41. Americas Intravitreal Injection Sales Market Share by Country in 2023
Figure 42. Americas Intravitreal Injection Revenue Market Share by Country in 2023
Figure 43. Americas Intravitreal Injection Sales Market Share by Type (2019-2024)
Figure 44. Americas Intravitreal Injection Sales Market Share by Application (2019-2024)
Figure 45. United States Intravitreal Injection Revenue Growth 2019-2024 ($ Millions)
Figure 46. Canada Intravitreal Injection Revenue Growth 2019-2024 ($ Millions)
Figure 47. Mexico Intravitreal Injection Revenue Growth 2019-2024 ($ Millions)
Figure 48. Brazil Intravitreal Injection Revenue Growth 2019-2024 ($ Millions)
Figure 49. APAC Intravitreal Injection Sales Market Share by Region in 2023
Figure 50. APAC Intravitreal Injection Revenue Market Share by Regions in 2023
Figure 51. APAC Intravitreal Injection Sales Market Share by Type (2019-2024)
Figure 52. APAC Intravitreal Injection Sales Market Share by Application (2019-2024)
Figure 53. China Intravitreal Injection Revenue Growth 2019-2024 ($ Millions)
Figure 54. Japan Intravitreal Injection Revenue Growth 2019-2024 ($ Millions)
Figure 55. South Korea Intravitreal Injection Revenue Growth 2019-2024 ($ Millions)
Figure 56. Southeast Asia Intravitreal Injection Revenue Growth 2019-2024 ($ Millions)
Figure 57. India Intravitreal Injection Revenue Growth 2019-2024 ($ Millions)
Figure 58. Australia Intravitreal Injection Revenue Growth 2019-2024 ($ Millions)
Figure 59. China Taiwan Intravitreal Injection Revenue Growth 2019-2024 ($ Millions)
Figure 60. Europe Intravitreal Injection Sales Market Share by Country in 2023
Figure 61. Europe Intravitreal Injection Revenue Market Share by Country in 2023
Figure 62. Europe Intravitreal Injection Sales Market Share by Type (2019-2024)
Figure 63. Europe Intravitreal Injection Sales Market Share by Application (2019-2024)
Figure 64. Germany Intravitreal Injection Revenue Growth 2019-2024 ($ Millions)
Figure 65. France Intravitreal Injection Revenue Growth 2019-2024 ($ Millions)
Figure 66. UK Intravitreal Injection Revenue Growth 2019-2024 ($ Millions)
Figure 67. Italy Intravitreal Injection Revenue Growth 2019-2024 ($ Millions)
Figure 68. Russia Intravitreal Injection Revenue Growth 2019-2024 ($ Millions)
Figure 69. Middle East & Africa Intravitreal Injection Sales Market Share by Country in 2023
Figure 70. Middle East & Africa Intravitreal Injection Revenue Market Share by Country in 2023
Figure 71. Middle East & Africa Intravitreal Injection Sales Market Share by Type (2019-2024)
Figure 72. Middle East & Africa Intravitreal Injection Sales Market Share by Application (2019-2024)
Figure 73. Egypt Intravitreal Injection Revenue Growth 2019-2024 ($ Millions)
Figure 74. South Africa Intravitreal Injection Revenue Growth 2019-2024 ($ Millions)
Figure 75. Israel Intravitreal Injection Revenue Growth 2019-2024 ($ Millions)
Figure 76. Turkey Intravitreal Injection Revenue Growth 2019-2024 ($ Millions)
Figure 77. GCC Country Intravitreal Injection Revenue Growth 2019-2024 ($ Millions)
Figure 78. Manufacturing Cost Structure Analysis of Intravitreal Injection in 2023
Figure 79. Manufacturing Process Analysis of Intravitreal Injection
Figure 80. Industry Chain Structure of Intravitreal Injection
Figure 81. Channels of Distribution
Figure 82. Global Intravitreal Injection Sales Market Forecast by Region (2025-2030)
Figure 83. Global Intravitreal Injection Revenue Market Share Forecast by Region (2025-2030)
Figure 84. Global Intravitreal Injection Sales Market Share Forecast by Type (2025-2030)
Figure 85. Global Intravitreal Injection Revenue Market Share Forecast by Type (2025-2030)
Figure 86. Global Intravitreal Injection Sales Market Share Forecast by Application (2025-2030)
Figure 87. Global Intravitreal Injection Revenue Market Share Forecast by Application (2025-2030)
Figure 1. Picture of Intravitreal Injection
Figure 2. Intravitreal Injection Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Intravitreal Injection Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Intravitreal Injection Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Intravitreal Injection Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Ranibizumab
Figure 10. Product Picture of Bevacizumab
Figure 11. Product Picture of Aflibercept
Figure 12. Product Picture of Brolucizumab
Figure 13. Product Picture of Faricimab
Figure 14. Product Picture of Others
Figure 15. Global Intravitreal Injection Sales Market Share by Type in 2023
Figure 16. Global Intravitreal Injection Revenue Market Share by Type (2019-2024)
Figure 17. Intravitreal Injection Consumed in Diabetic Eye Disease
Figure 18. Global Intravitreal Injection Market: Diabetic Eye Disease (2019-2024) & (K Units)
Figure 19. Intravitreal Injection Consumed in AMD
Figure 20. Global Intravitreal Injection Market: AMD (2019-2024) & (K Units)
Figure 21. Intravitreal Injection Consumed in Retinal Vein Occlusion
Figure 22. Global Intravitreal Injection Market: Retinal Vein Occlusion (2019-2024) & (K Units)
Figure 23. Intravitreal Injection Consumed in Others
Figure 24. Global Intravitreal Injection Market: Others (2019-2024) & (K Units)
Figure 25. Global Intravitreal Injection Sales Market Share by Application (2023)
Figure 26. Global Intravitreal Injection Revenue Market Share by Application in 2023
Figure 27. Intravitreal Injection Sales Market by Company in 2023 (K Units)
Figure 28. Global Intravitreal Injection Sales Market Share by Company in 2023
Figure 29. Intravitreal Injection Revenue Market by Company in 2023 ($ Million)
Figure 30. Global Intravitreal Injection Revenue Market Share by Company in 2023
Figure 31. Global Intravitreal Injection Sales Market Share by Geographic Region (2019-2024)
Figure 32. Global Intravitreal Injection Revenue Market Share by Geographic Region in 2023
Figure 33. Americas Intravitreal Injection Sales 2019-2024 (K Units)
Figure 34. Americas Intravitreal Injection Revenue 2019-2024 ($ Millions)
Figure 35. APAC Intravitreal Injection Sales 2019-2024 (K Units)
Figure 36. APAC Intravitreal Injection Revenue 2019-2024 ($ Millions)
Figure 37. Europe Intravitreal Injection Sales 2019-2024 (K Units)
Figure 38. Europe Intravitreal Injection Revenue 2019-2024 ($ Millions)
Figure 39. Middle East & Africa Intravitreal Injection Sales 2019-2024 (K Units)
Figure 40. Middle East & Africa Intravitreal Injection Revenue 2019-2024 ($ Millions)
Figure 41. Americas Intravitreal Injection Sales Market Share by Country in 2023
Figure 42. Americas Intravitreal Injection Revenue Market Share by Country in 2023
Figure 43. Americas Intravitreal Injection Sales Market Share by Type (2019-2024)
Figure 44. Americas Intravitreal Injection Sales Market Share by Application (2019-2024)
Figure 45. United States Intravitreal Injection Revenue Growth 2019-2024 ($ Millions)
Figure 46. Canada Intravitreal Injection Revenue Growth 2019-2024 ($ Millions)
Figure 47. Mexico Intravitreal Injection Revenue Growth 2019-2024 ($ Millions)
Figure 48. Brazil Intravitreal Injection Revenue Growth 2019-2024 ($ Millions)
Figure 49. APAC Intravitreal Injection Sales Market Share by Region in 2023
Figure 50. APAC Intravitreal Injection Revenue Market Share by Regions in 2023
Figure 51. APAC Intravitreal Injection Sales Market Share by Type (2019-2024)
Figure 52. APAC Intravitreal Injection Sales Market Share by Application (2019-2024)
Figure 53. China Intravitreal Injection Revenue Growth 2019-2024 ($ Millions)
Figure 54. Japan Intravitreal Injection Revenue Growth 2019-2024 ($ Millions)
Figure 55. South Korea Intravitreal Injection Revenue Growth 2019-2024 ($ Millions)
Figure 56. Southeast Asia Intravitreal Injection Revenue Growth 2019-2024 ($ Millions)
Figure 57. India Intravitreal Injection Revenue Growth 2019-2024 ($ Millions)
Figure 58. Australia Intravitreal Injection Revenue Growth 2019-2024 ($ Millions)
Figure 59. China Taiwan Intravitreal Injection Revenue Growth 2019-2024 ($ Millions)
Figure 60. Europe Intravitreal Injection Sales Market Share by Country in 2023
Figure 61. Europe Intravitreal Injection Revenue Market Share by Country in 2023
Figure 62. Europe Intravitreal Injection Sales Market Share by Type (2019-2024)
Figure 63. Europe Intravitreal Injection Sales Market Share by Application (2019-2024)
Figure 64. Germany Intravitreal Injection Revenue Growth 2019-2024 ($ Millions)
Figure 65. France Intravitreal Injection Revenue Growth 2019-2024 ($ Millions)
Figure 66. UK Intravitreal Injection Revenue Growth 2019-2024 ($ Millions)
Figure 67. Italy Intravitreal Injection Revenue Growth 2019-2024 ($ Millions)
Figure 68. Russia Intravitreal Injection Revenue Growth 2019-2024 ($ Millions)
Figure 69. Middle East & Africa Intravitreal Injection Sales Market Share by Country in 2023
Figure 70. Middle East & Africa Intravitreal Injection Revenue Market Share by Country in 2023
Figure 71. Middle East & Africa Intravitreal Injection Sales Market Share by Type (2019-2024)
Figure 72. Middle East & Africa Intravitreal Injection Sales Market Share by Application (2019-2024)
Figure 73. Egypt Intravitreal Injection Revenue Growth 2019-2024 ($ Millions)
Figure 74. South Africa Intravitreal Injection Revenue Growth 2019-2024 ($ Millions)
Figure 75. Israel Intravitreal Injection Revenue Growth 2019-2024 ($ Millions)
Figure 76. Turkey Intravitreal Injection Revenue Growth 2019-2024 ($ Millions)
Figure 77. GCC Country Intravitreal Injection Revenue Growth 2019-2024 ($ Millions)
Figure 78. Manufacturing Cost Structure Analysis of Intravitreal Injection in 2023
Figure 79. Manufacturing Process Analysis of Intravitreal Injection
Figure 80. Industry Chain Structure of Intravitreal Injection
Figure 81. Channels of Distribution
Figure 82. Global Intravitreal Injection Sales Market Forecast by Region (2025-2030)
Figure 83. Global Intravitreal Injection Revenue Market Share Forecast by Region (2025-2030)
Figure 84. Global Intravitreal Injection Sales Market Share Forecast by Type (2025-2030)
Figure 85. Global Intravitreal Injection Revenue Market Share Forecast by Type (2025-2030)
Figure 86. Global Intravitreal Injection Sales Market Share Forecast by Application (2025-2030)
Figure 87. Global Intravitreal Injection Revenue Market Share Forecast by Application (2025-2030)
